DE3870064D1 - Waessrige loesungen von doxorubicinhydrochlorid. - Google Patents

Waessrige loesungen von doxorubicinhydrochlorid.

Info

Publication number
DE3870064D1
DE3870064D1 DE8888111433T DE3870064T DE3870064D1 DE 3870064 D1 DE3870064 D1 DE 3870064D1 DE 8888111433 T DE8888111433 T DE 8888111433T DE 3870064 T DE3870064 T DE 3870064T DE 3870064 D1 DE3870064 D1 DE 3870064D1
Authority
DE
Germany
Prior art keywords
aqueous solutions
doxorubicin hydrochloride
doxorubicin hcl
solutions
butylhydroquinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888111433T
Other languages
English (en)
Inventor
Murray Arthur Kaplan
Robert Kevin Perrone
Joseph Ballard Dr Bogardus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE3870064D1 publication Critical patent/DE3870064D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8888111433T 1987-07-16 1988-07-15 Waessrige loesungen von doxorubicinhydrochlorid. Expired - Fee Related DE3870064D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7419087A 1987-07-16 1987-07-16

Publications (1)

Publication Number Publication Date
DE3870064D1 true DE3870064D1 (de) 1992-05-21

Family

ID=22118217

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888111433T Expired - Fee Related DE3870064D1 (de) 1987-07-16 1988-07-15 Waessrige loesungen von doxorubicinhydrochlorid.

Country Status (11)

Country Link
EP (1) EP0299527B1 (de)
JP (1) JPH0655668B2 (de)
KR (1) KR920004097B1 (de)
AT (1) ATE74759T1 (de)
AU (1) AU612379B2 (de)
DE (1) DE3870064D1 (de)
DK (1) DK396288A (de)
ES (1) ES2033379T3 (de)
FI (1) FI883338A (de)
GR (1) GR3004383T3 (de)
PT (1) PT88016B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI895733A0 (fi) * 1988-12-05 1989-11-30 Bristol Myers Squibb Co Vattenloesningar av doxorubicin.
JP3236608B2 (ja) * 1990-10-04 2001-12-10 日本化薬株式会社 ブレオマイシン類の安定な水溶液
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
KR100327400B1 (ko) * 1998-04-07 2002-05-09 구자홍 음극선관용편향요크
RU2162699C1 (ru) * 2000-02-14 2001-02-10 Закрытое Акционерное Общество "Нита-Фарм" Водно-дисперсная лекарственная форма ивермектина для лечения экто- и эндопаразитозов
JP2002037737A (ja) * 2001-08-02 2002-02-06 Nippon Kayaku Co Ltd ブレオマイシン類の安定な水溶液
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
KR20070088447A (ko) * 2005-05-11 2007-08-29 시코르, 인크. 안정한 동결건조된 안트라사이클린 글리코시드
WO2007075092A1 (en) * 2005-12-29 2007-07-05 Instytut Biochemii I Biofizyki New derivatives of epirubicin, their medicinal application and pharmaceuticals acceptable forms of drugs
HRP20240485T1 (hr) 2017-08-24 2024-07-05 Novo Nordisk A/S Pripravci glp-1 i njihova upotreba
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191847A (en) * 1978-10-20 1982-05-31 Lilly Co Eli Stabilized pharmaceutical solutions of erythromycin
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
PT88016A (pt) 1989-06-30
ES2033379T3 (es) 1993-03-16
EP0299527B1 (de) 1992-04-15
JPH01117894A (ja) 1989-05-10
FI883338A (fi) 1989-01-17
DK396288D0 (da) 1988-07-15
KR920004097B1 (ko) 1992-05-25
AU612379B2 (en) 1991-07-11
JPH0655668B2 (ja) 1994-07-27
KR890001571A (ko) 1989-03-27
GR3004383T3 (de) 1993-03-31
FI883338A0 (fi) 1988-07-13
PT88016B (pt) 1995-03-01
ATE74759T1 (de) 1992-05-15
EP0299527A1 (de) 1989-01-18
AU1905388A (en) 1989-01-19
DK396288A (da) 1989-01-17

Similar Documents

Publication Publication Date Title
FI870169A0 (fi) Stabiliserat tokoferol i fri-flytande partikelform.
NO872127L (no) Vandige steroidpreparater for administrering gjennom nesen
DE3870064D1 (de) Waessrige loesungen von doxorubicinhydrochlorid.
ES2052646T3 (es) Solucion no acuosa de hidrocloruro de doxorubicina.
DE68902223D1 (de) Waesserige loesungen von doxorubicin.
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
DE68905577D1 (de) Doxorubicin-loesungen.
GB2162746A (en) Antiacidotic medicinal agent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee